TCGA was established to address the critical need for a detailed understanding of the genetic changes that drive various types of cancer. Traditional methods of studying cancer were insufficient in revealing the intricate genetic landscape of tumors. TCGA provides an extensive database of molecular and clinical data that helps researchers identify potential biomarkers and therapeutic targets, which can lead to personalized medicine approaches.